Pfizer Inc., 10% Owner at Pyxis Oncology, Inc. (PYXS), bought 3,623,188 shares at $2.76 ($10.0M) on 2023-03-17, disclosed to the SEC on 2023-03-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.76 | 1,811,594 | $5.0M | 50.0% |
| 2 | $2.76 | 1,811,594 | $5.0M | 50.0% |
| Total | $2.76 avg | 3,623,188 | $10.0M | 100% |
| Filing → |
| ALLO | BUY | 2018-10-17 | $1.0M | — | Filing → |
| RYTM | BUY | 2017-10-10 | $680K | — | Filing → |
| MIRN | BUY | 2015-10-07 | $5.0M | — | Filing → |